CSRP3 and cardiac hypertrophy: Previous research has proven that the calcineurin‐NFAT pathway participates in cardiac hypertrophy and that the muscle LIM protein is required for calcineurin‐NFAT signalling at the sarcomeric Z disc.28, 29 Consequently, our study examined whether TES modulates cardiac hypertrophy via the calcineurin‐NFAT axis.